As of January 2025, Mayinglong Pharmaceutical Group has a market cap of $1.55B. This makes Mayinglong Pharmaceutical Group the world's 5961th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.36B | -4.59% |
2023 | $1.43B | 6.99% |
2022 | $1.34B | -21.42% |
2021 | $1.70B | 42.80% |
2020 | $1.19B | 15.15% |
2019 | $1.03B | 30.33% |
2018 | $792.87M | -34.47% |
2017 | $1.21B | 2.55% |
2016 | $1.18B | -9.31% |
2015 | $1.30B | 41.15% |
2014 | $921.66M | 17.09% |
2013 | $787.14M | 23.54% |
2012 | $637.16M | -18.91% |
2011 | $785.78M | -24.22% |
2010 | $1.04B | 19.01% |
2009 | $871.22M | 185.41% |
2008 | $305.25M | -43.32% |
2007 | $538.54M | 141.40% |
2006 | $223.10M | 58.65% |
2005 | $140.62M | 6.70% |
2004 | $131.79M | - |